208 related articles for article (PubMed ID: 21941577)
21. Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.
Harada Y; Sakatsume M; Taniguchi M
Jpn J Cancer Res; 1990 Apr; 81(4):383-7. PubMed ID: 2142151
[TBL] [Abstract][Full Text] [Related]
22. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
[TBL] [Abstract][Full Text] [Related]
23. Postnatal change of pig intestinal ganglioside bound by Escherichia coli with K99 fimbriae.
Yuyama Y; Yoshimatsu K; Ono E; Saito M; Naiki M
J Biochem; 1993 Apr; 113(4):488-92. PubMed ID: 8514738
[TBL] [Abstract][Full Text] [Related]
24. A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.
Casadesús AV; Fernández-Marrero Y; Clavell M; Gómez JA; Hernández T; Moreno E; López-Requena A
Glycoconj J; 2013 Oct; 30(7):687-99. PubMed ID: 23547010
[TBL] [Abstract][Full Text] [Related]
25. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3.
Krengel U; Olsson LL; Martínez C; Talavera A; Rojas G; Mier E; Angström J; Moreno E
J Biol Chem; 2004 Feb; 279(7):5597-603. PubMed ID: 14627696
[TBL] [Abstract][Full Text] [Related]
26. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
[TBL] [Abstract][Full Text] [Related]
27. Racotumomab for treating lung cancer and pediatric refractory malignancies.
Gabri MR; Cacciavillano W; Chantada GL; Alonso DF
Expert Opin Biol Ther; 2016; 16(4):573-8. PubMed ID: 26903265
[TBL] [Abstract][Full Text] [Related]
28. [GM3 ganglioside as melanoma specific antigen and its biological function].
Hirabayashi Y; Taniguchi M
Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
[TBL] [Abstract][Full Text] [Related]
29. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
[TBL] [Abstract][Full Text] [Related]
30. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.
Furukawa K; Thampoe IJ; Yamaguchi H; Lloyd KO
J Immunol; 1989 Feb; 142(3):848-54. PubMed ID: 2464027
[TBL] [Abstract][Full Text] [Related]
31. Hydroxylation of CMP-NeuAc controls the expression of N-glycolylneuraminic acid in GM3 ganglioside of the small intestine of inbred rats.
Bouhours JF; Bouhours D
J Biol Chem; 1989 Oct; 264(29):16992-9. PubMed ID: 2793841
[TBL] [Abstract][Full Text] [Related]
32. Insights into the immunogenetic basis of two ganglioside-associated idiotypic networks.
Rodríguez M; Roque-Navarro L; López-Requena A; Moreno E; Mateo de Acosta C; Pérez R; María Vázquez A
Immunobiology; 2007; 212(1):57-70. PubMed ID: 17270710
[TBL] [Abstract][Full Text] [Related]
33. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody.
Vázquez AM; Pérez A; Hernández AM; Macías A; Alfonso M; Bombino G; Pérez R
Hybridoma; 1998 Dec; 17(6):527-34. PubMed ID: 9890708
[TBL] [Abstract][Full Text] [Related]
34. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
Hirabayashi Y; Hamaoka A; Matsumoto M; Matsubara T; Tagawa M; Wakabayashi S; Taniguchi M
J Biol Chem; 1985 Oct; 260(24):13328-33. PubMed ID: 2414279
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
[TBL] [Abstract][Full Text] [Related]
36. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the
Bousquet PA; Manna D; Sandvik JA; Arntzen MØ; Moreno E; Sandvig K; Krengel U
Front Immunol; 2022; 13():994790. PubMed ID: 36439103
[TBL] [Abstract][Full Text] [Related]
37. Ganglioside GM1 and GM3 in early human brain development: an immunocytochemical study.
Stojiljković M; Blagojević T; Vukosavić S; Zvezdina ND; Peković S; Nikezić G; Rakić L
Int J Dev Neurosci; 1996 Feb; 14(1):35-44. PubMed ID: 8779306
[TBL] [Abstract][Full Text] [Related]
38. Ganglioside GM3 and Its Role in Cancer.
Zheng C; Terreni M; Sollogoub M; Zhang Y
Curr Med Chem; 2019; 26(16):2933-2947. PubMed ID: 29376491
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.
Blanco R; Rengifo E; Cedeño M; Rengifo CE; Alonso DF; Carr A
ISRN Gastroenterol; 2011; 2011():645641. PubMed ID: 21991524
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.
He D; Fan X; Liu B; Tian Y; Zhang X; Kang L; Tai Y; Liu S; Wang Q; Li Q; Cai J
Sci Rep; 2018 Feb; 8(1):2561. PubMed ID: 29416099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
